Holding up really well. Maybe some people are buying on the dip, but I don't believe we have bottomed yet.I see fair value around the $4 mark. Possibly a bit lower, given that the raising was priced way too high.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025